Adage Capital Partners’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.53M Sell
67,600
-305,636
-82% -$18.3M 0.01% 801
2025
Q4
$22M Buy
373,236
+230,536
+162% +$14M 0.03% 454
2025
Q3
$7.94M Sell
142,700
-125,900
-47% -$6.74M 0.01% 673
2025
Q2
$13.8M Sell
268,600
-25,700
-9% -$1.29M 0.02% 537
2025
Q1
$17.3M Sell
294,300
-204,200
-41% -$13.8M 0.03% 456
2024
Q4
$35.9M Buy
498,500
+175,000
+54% +$12.9M 0.06% 284
2024
Q3
$25.9M Buy
+323,500
New +$24.3M 0.05% 385
2024
Q1
Sell
-353,600
Closed -$27.3M 947
2023
Q4
$27.3M Buy
353,600
+197,100
+126% +$13M 0.06% 341
2023
Q3
$10.7M Sell
156,500
-400
-0.3% -$31.6K 0.02% 548
2023
Q2
$12.8M Buy
156,900
+74,400
+90% +$5.98M 0.03% 519
2023
Q1
$6.12M Sell
82,500
-17,200
-17% -$1.33M 0.01% 683
2022
Q4
$8.26M Sell
99,700
-60,300
-38% -$4.79M 0.02% 678
2022
Q3
$11.4M Sell
160,000
-3,600
-2% -$311K 0.03% 603
2022
Q2
$14.2M Sell
163,600
-400
-0.2% -$37.5K 0.03% 572
2022
Q1
$17.8M Sell
164,000
-3,600
-2% -$371K 0.03% 509
2021
Q4
$21.7M Hold
167,600
0.04% 439
2021
Q3
$20.3M Buy
+167,600
New +$20.4M 0.04% 445
2017
Q4
Sell
-240,000
Closed -$7.25M 746
2017
Q3
$7.25M Buy
+240,000
New +$7.12M 0.02% 597
2014
Q4
Sell
-201,064
Closed -$4.7M 764
2014
Q3
$4.7M Buy
+201,064
New +$4.71M 0.01% 621

Other funds holding TECH

Adage Capital Partners's TECH Position: Q1 2026 in Review

Adage Capital Partners reduced its Bio-Techne (TECH) stake by 82% in Q1 2026, selling an estimated $18.3M and leaving 67,600 shares worth $3.53M. The position accounts for 0.01% of the portfolio, ranked #801.

Adage Capital Partners first reported a position in TECH in Q3 2014 and has held it in 19 quarters since. The position peaked at $35.9M in Q4 2024. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Adage Capital Partners held 67,600 shares of Bio-Techne worth $3.53M as of Q1 2026.
  • Adage Capital Partners sold 305,636 Bio-Techne shares in Q1 2026, an estimated $18.3M.
  • Bio-Techne made up 0.01% of Adage Capital Partners's portfolio in Q1 2026, its #801 holding.
  • Adage Capital Partners first reported a position in Bio-Techne in Q3 2014 and has held it in 19 quarters since.
  • Adage Capital Partners's Bio-Techne position peaked at $35.9M in Q4 2024.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.